Temporal evaluation of RAS mutation by liquid biopsy at progression after bevacizumab-based treatment in patients with metastatic colorectal cancer

Tracking cancer mutations in blood over time reveals how tumors evolve during bevacizumab treatment progression.

What the study was

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.